Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

Musk’s Neuralink faces federal inquiry after killing 1,500 animals in testing

Brain-implant company accused of causing needless suffering and deaths amid pressure from CEO

The Guardian - US

Pfizer asks FDA to clear updated COVID shot for kids under 5

Pfizer is asking U.S. regulators to authorize its updated COVID-19 vaccine for children under age 5

The Independent UK

FDA change ushers in cheaper, easier-to-get hearing aids

It's now a lot easier and cheaper for Americans to get hearing aids

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

In the hunt for a male contraceptive, scientists look to stop sperm in their tracks

For decades birth control research focused on women. Now there's a new push to develop gels, pills or other products that could keep men from getting their partners pregnant.

WEKU

3 Stocks You'll Regret Not Buying This Year

With slowing inflation, indications of slower rate hikes by the Fed beginning this month, and resilient employment growth, fundamentally strong stocks Biogen (BIIB), APA Corporation (APA), and Nathan’s Famous (NATH) seem to be good investments now. Continue reading….

StockNews.com

Sexually Active Gay Men May Soon Be Able To Donate Blood in America

Men in monogamous relationships may get clearance to give.

Reason

FDA moves to ease blood donor restrictions on gay men amid national shortage

The FDA is considering easing blood donor screening restrictions for gay and bisexual men.

Axios

Read news from The Economist, FT, and more,
with one subscription

New Alzheimer's drug shows modest slowing of early disease progression

Scientists are cautiously optimistic about the promise of an experimental drug shown to modestly slow the progression of Alzheimer's disease in some patients.

ABC News

Elon Musk's Neuralink demo promised miracles — but a neuroscientist says the tech is decades behind

The brain-computer interface technology touted by Neuralink has been around for several decades.

Inverse

Elon Musk wants to put Neuralink implants in people’s brains within 6 months

Would you let Elon Musk’s company put a computer chip in your brain?

Evening Standard

Can health wearables help you sleep better? Here’s what your trackers are actually measuring

While most sleep trackers capture information on heart rate, oxygen levels, or movement, these metrics aren’t measuring sleep quality directly.

Inverse

FDA clears 1st fecal transplant treatment for gut infection

U.S. officials approved the first pharmaceutical-grade version of the fecal transplant procedures that doctors have increasingly used to treat a potentially life-threatening intestinal infection

The Independent UK

Mark Cuban’s prescription drug company in talks with hospitals to fill drug shortages

Mark Cuban’s prescription drug company, known for “cutting out the middle man,” is in conversations with hospitals around the nation to identify the most common drug shortages.

Tribune News Service

Data shows drug slowing Alzheimer’s but doubts over effect remain

Lecanemab modestly slows disease’s inevitable worsening, but it remains unclear how much of a difference it will make.

Al Jazeera

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune

Laid off workers can now get a free month of ketamine assisted therapy services to help with their mental health

The free service from Field Trip Health is open to "anyone who's facing headwinds right now."

StockNews.com

3 Stocks That Still Have Room to Run

With the October inflation report showing signs of cooling and anticipations of a slowdown in interest rate hikes, the stock market looks poised to extend its recent rally. Hence, it could be wise to invest in fundamentally sound stocks Pfizer (PFE), Cisco Systems (CSCO), and Raytheon Technologies (RTX) that still…

Axios

New Alzheimer's drug faces uncertain regulatory path

The FDA will soon decide whether to approve Eisai's experimental drug lecanemab.

WEKU

Study: Alzheimer's drug shows modest success slowing declines in memory, thinking

In a large study, the experimental Alzheimer's drug lecanemab reduced the rate of cognitive decline by 27 percent in people in the early stages of the disease.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Drug slows Alzheimer's but can it make a real difference?

New data shows an experimental Alzheimer's drug modestly slowed the brain disease's inevitable worsening

The Independent UK

Vet's lawsuit blaming antimalarial drug for psychosis tossed

A lawsuit against the maker of an anti-malarial drug blamed for causing psychotic and neurological damage in U.S. servicemembers has been thrown out

Axios

Safety concerns hang over new Alzheimer's treatment

Two deaths linked to the drug may present a more complicated path to approval.

WEKU

The chase is on: Regulators are slowly cracking down on vapes aimed at teens

The advent of vaping revived nicotine addiction among young people after a dramatic decline. The FDA seems poised to at last yank some products aimed at teens from the market. Will it work?

StockNews.com

1 High-Dividend Stock to Add to Your Portfolio if You Haven’t Already

Amid prevalent COVID-19 cases, vaccine pioneer Pfizer (PFE) is significantly benefiting. Moreover, the company beat wall street expectations in the third quarter with a robust financial result and raised its revenue and EPS guidance for the year. Given its strong fundamentals, the stock could be a wise addition to your…

Bangkok Post

NVI plans to utilise local booster shots

The National Vaccine Institute (NVI) plans to use locally developed Covid-19 vaccines as booster shots when they are completed and approved by the Food and Drug Administration (FDA).

StockNews.com

3 Strong Buy Stocks to Continue to Hold Onto in 2023

As the Fed’s aggressive monetary policy resulted in slightly cooled inflation last month, investors are hopeful of smaller rate hikes ahead. However, since a recession is expected to hit the economy next year, we think fundamentally sound stocks Pfizer (PFE), Flowers Foods (FLO), and Xperi (XPER), which are rated Strong…

1 … 177 178 179 180

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.